Delivery Order SPE2DB22D1106-SPE2DB25FESH2
- Not listed
- The Defense Logistics Agency (DLA) awarded a $4,267.23 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4,565,482,490 units of Prilosec DR 2.5 mg suspension 30-count. This delivery order falls under an existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Prilosec DR 2.5 mg suspension (30-count units) with a ceiling value of $1,155.57. This competitively awarded, firm fixed-price delivery order is classified as a child contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 11, 2025. No set-aside designation was utilized for this...
- The Defense Logistics Agency awarded a delivery order valued at $2,087.69 to AmerisourceBergen Drug Corp for PRILOSEC DR 10 MG Suspension (30-count) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,722.17 firm fixed-price contract is for the supply of Prilosec DR 10 mg suspension medication, with a completion date of December 24, 2024. This contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Prilosec DR 10 mg Suspension, a prescription medication, with a ceiling value of $10,532.34 and a performance period through July 10, 2023. The contract is a firm fixed-price delivery order and is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a $5,654.86 firm fixed price delivery order to Amerisourcebergen Drug Corp for 30 units of Prilosec 2.5 mg suspension. As the prime contractor, Amerisourcebergen Drug will deliver the specified pharmaceutical product to a location in Conshohocken, Pennsylvania by August 23, 2023 in support of the Defense Logistics Agency's medical supply needs. Amerisourcebergen Corporation is the identified parent company of Amerisourcebergen Drug Corp, the prime...
- This federal contract award is for the delivery of Prilosec DR 2.5 mg suspension 30s to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $2,105.68, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Omeprazole DR 20 mg capsules in quantities of 1,000 units. This non-competitive, firm fixed-price delivery order has a ceiling value of $1,472.29 and is scheduled for completion by September 5, 2025. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child...
- The Defense Logistics Agency awarded a $1,533.60 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of 500 capsules of Omeprazole DR 40 mg. This is a non-set-aside contract with an ultimate completion date of July 28, 2025, and represents a delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The work will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,256.67 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Omeprazole DR 20 mg capsules (1,000 units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 6, 2025, to be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FESH2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,346.17 to AmerisourceBergen Drug Corp on June 7, 2025, for the supply of Prilosec DR 10 mg suspension (30 count). This competitively awarded, firm fixed price delivery order is set to be completed by June 9, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs within DLA's comprehensive medical supply chain operations. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen leverages this prime contract vehicle to supply a broad range of pharmaceutical products and medical supplies to support military and federal healthcare systems. The company's demonstrated capability to fulfill competitive federal procurements across multiple therapeutic domains positions it as a critical vendor within the military's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 6/7/25 |